Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve and take on record the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September, 2026

Date: 24th October, 2026 BSE Limited National Stock Exchange of India Limited Dept. of Corporate Services, Dept. of Corporate Compliances, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 BSE Scrip Code - 541304 NSE Symbol: INDOUS Subject: Intimation of Board Meeting to be held on 30th October, 2026 Dear Sir, Notice is hereby given to the Stock Exchanges under Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 30th October, 2026, To consider, approve and take on record the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September, 2026 and to consider any other matter with the permission of the Board. Please take the same on your record. Thanking You, Yours Faithfully, For, Indo Us Bio Tech Limited Ms. Dimpy Joshi Company Secretary & Compliance officer